Global Microfluidics Market 2018-2022 By Material (Ceramics, Polymers), Components (Microfluidic Chips, Pumps, Needles) & Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - ResearchAndMarkets.com

DUBLIN--()--The "Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022" report has been added to ResearchAndMarkets.com's offering.

The market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022).

The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.

On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

5. Drivers & Challenges

6. Market Segmentation

7. Regulatory Scenario

8. Trends & Developments

9. Competitive Assessment

  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Perkin Elmer, Inc.
  • Illumina, Inc.
  • Shimadzu Corporation
  • Danaher Corporation
  • Abbott

For more information about this report visit https://www.researchandmarkets.com/research/lt84rp/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery, Drug Discovery, In Vitro Diagnostics, Infusions and Injectables, Needles and Syringes

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery, Drug Discovery, In Vitro Diagnostics, Infusions and Injectables, Needles and Syringes